WDR-5-0103

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameWDR-5-0103
Drug Alias NameWDR5-0103WDR-5-0103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase 2A inhibitorsWD repeat-containing protein 5 inhibitors
TargetsWD repeat-containing protein 5Histone-lysine N-methyltransferase 2A
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Toronto, Toronto
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Toronto, Toronto
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A